Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

688363.SS

SELLREMOVE

Bloomage BioTechnology Corporation Limited · Basic Materials · China · $2.6B · Avg Vol: $18M/d

24
StockRank
Q
67
V
23
M
24
P/E (TTM)
67.2x
ROE
3.6%
D/E
0.1x
Dividend %
0.5%
AI CONVICTION THESIS

Bloomage is a leading producer of hyaluronic acid. While it has historically been a high-quality business, it is currently facing intense domestic price competition and margin erosion in its raw materials division. It does not align with our active macro themes, and its valuation remains demanding relative to slowing growth.

COMPANY DESCRIPTION

Bloomage BioTechnology Corporation Limited is the world's largest manufacturer of hyaluronic acid (HA) raw materials, serving the pharmaceutical, cosmetic, and food industries. The company has successfully built a vertically integrated business model, expanding into high-margin medical aesthetics and functional skincare products. Its competitive moat is sustained by massive economies of scale, proprietary microbial fermentation technology, and strong brand equity in the consumer market.

FINANCIAL SUMMARY (USD)

Year2022202320242025CAGR
Revenue940M898M794M621M-12.9%
EPS0.300.180.050.09-32.9%
Shares481M482M482M482M+0.1%
Debt58M31M53M50M-4.3%
Equity980M1.0B1.0B1.0B2.2%
Op CF94M103M83M93M-0.4%
Inv CF-124M-91M-68M-39M
Fin CF-25M-78M-46M-339,836
Loading...
PRICE (1M)-14.8%
4.935.245.565.886.19May 8May 29Jun 18
SMA 50SMA 200
Close
$5.27
RSI (14)
44.2
52W High
$9.14
From 52W High
0.6%

SCORE BREAKDOWN

Quality
67
ROIC
4.5%52.9
ROE
3.6%49.4
GP/Assets
30.4%86.0
Op. Margin
10.8%68.4
FCF/Assets
4.4%73.0
Piotroski
81.2
Int. Cover
50.0x93.3
D/E Ratio
0.06x75.6
Current Ratio
2.36x56.3
Value
23
P/E (TTM)
67.2x16.5
EV/EBITDA
33.5x9.9
P/FCF
313.0x26.3
P/B
2.4x41.8
P/S
4.4x26.9
Div Yield
0.5%21.9
Momentum
24
52W High %
58%24.2
RS 6M
-32%23.0
SMA 50/200
0.84x7.4
EPS Rev 4W
N/A
EPS Rev 12W
N/A
EPS Improve
+77%53.7
Q Growth
-37%14.1

FUNDAMENTALS

Market Cap
$2.6B
P/E (Forward)
38.0x
Gross Margin
66.6%

SECTOR PEERS

Closest peers in Basic Materials, ranked by industry match, size, and score similarity. Cross-listings of 688363.SS are excluded.

TickerCompanyMkt CapStockRankSignal
688363.SSBloomage BioTechnology Corporation Limited(you)$2.6B24SELL
002408.SZZibo Qixiang Tengda Chemical Co., Ltd$2.1B24SELL
688708.SSChengdu Jiachi Electronic Technology Co., Ltd.$3.0B27SELL
300655.SZCrystal Clear Electronic Material Co.,Ltd$2.4B18STRONG SELL
688116.SSJiangsu Cnano Technology Co., Ltd.$2.4B18STRONG SELL
603360.SSDalian BIO-CHEM Company Limited$2.2B18STRONG SELL
002361.SZAnhui Shenjian New Materials Co.,Ltd$2.1B18STRONG SELL
2768.HKQingdao Gon Technology Co., Ltd.$2.2B31SELL
600409.SSTangshan Sanyou Chemical Industries Co.,Ltd$1.9B18STRONG SELL
002053.SZYunnan Energy Investment Co., Ltd.$1.6B25SELL

Peer medians: ROE 6.2% · P/E 33.1x · Gross margin 17.5%

Bloomage BioTechnology Corporation Limited (688363.SS) — Stock Score Summary

Bloomage BioTechnology Corporation Limited (688363.SS) has a MoatMap StockRank of 24/100 based on Quality (67/100), Value (23/100), and Momentum (24/100) factor scores. The current signal is SELL. Bloomage is a leading producer of hyaluronic acid. While it has historically been a high-quality business, it is currently facing intense domestic price competition and margin erosion in its raw materials division. It does not align with our active macro themes, and its valuation remains demanding relative to slowing growth.

Bloomage BioTechnology Corporation Limited is the world's largest manufacturer of hyaluronic acid (HA) raw materials, serving the pharmaceutical, cosmetic, and food industries. The company has successfully built a vertically integrated business model, expanding into high-margin medical aesthetics and functional skincare products. Its competitive moat is sustained by massive economies of scale, proprietary microbial fermentation technology, and strong brand equity in the consumer market.

Key Financial Metrics

Price$5.27
Market Cap$2.6B
P/E (TTM)67.17
P/E (Forward)37.98
Price/Book2.43
Return on Equity3.6%
Return on Invested Capital4.5%
Debt/Equity5.51
Gross Margin66.6%
Operating Margin10.8%
Revenue Growth-23.1%
Dividend Yield0.5%
Free Cash Flow$8M

Bloomage BioTechnology Corporation Limited operates in the Specialty Chemicals industry, part of the Basic Materials sector (China).

Frequently Asked Questions

What is Bloomage BioTechnology Corporation Limited’s (688363.SS) StockRank?
MoatMap’s StockRank for Bloomage BioTechnology Corporation Limited (688363.SS) is 24/100, with a Sell signal. It is a composite of Quality (67), Value (23), and Momentum (24) factor ranks across MoatMap’s 20,000+ stock universe.
Does Bloomage BioTechnology Corporation Limited have an economic moat?
Bloomage BioTechnology Corporation Limited (688363.SS) has a Quality factor score of 67/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Bloomage BioTechnology Corporation Limited a buy, hold, or sell?
MoatMap’s current signal for Bloomage BioTechnology Corporation Limited (688363.SS) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Bloomage BioTechnology Corporation Limited in?
Bloomage BioTechnology Corporation Limited (688363.SS) operates in the Basic Materials sector, specifically the Specialty Chemicals industry (China).